col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


34 Ergebisse       Seite 1

 [1] 
Elsevier: Seminars in Arthritis and Rheumatism
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2026―Jan―02 COVID-19 vaccination and systemic autoimmune rheumatic diseases: no evidence of disproportionately increased reporting in VAERS Jacopo Ciaffi, Ginevra Torrigiani, Piero Ruscitti, Antonella Zambon, Francesco Ursini
2 [GO] 2025―Sep―05 No disproportionate reporting of inflammatory arthritis following COVID-19 vaccination: a pharmacovigilance study using VAERS data Jacopo Ciaffi, Ginevra Torrigiani, Piero Ruscitti, Antonella Zambon, Francesco Ursini
3 [GO] 2025―Aug―05 Risk of new onset of immune-mediated diseases after SARS-CoV-2 infection: A Systematic Review and Meta-analysis Ana M. Gil, Julián Barahona-Correa, Jorge B. Flórez, Daniel G. Fernández-Ávila, Zulma M. Cucunubá
4 [GO] 2025―Feb―11 Impact long COVID on self-reported disease activity, disability, and quality of life in individuals with inflammatory arthritis Zachary S. Wallace, Miao Lin, Shruthi Srivatsan, Andrew King, Xiaosong Wang, Rathnam Venkat, et al. (+16)
5 [GO] 2024―Nov―17 The Overlooked Epidemic: Fibromyalgia in the Shadows of Long COVID Mariangela Salvato, Andrea Doria, Alessandro Giollo
6 [GO] 2024―Mai―09 COVID-19 vaccinations and infections among individuals with systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study Kimberly S. Lakin, Yin Wu, Jessica K. Gordon, Linda Kwakkenbos, Marie-Eve Carrier, Richard S. Henry, et al. (+6)
7 [GO] 2024―Mai―07 How to Understand the Overlap of Long COVID, Chronic Fatigue Syndrome/Myalgic Encephalomyelitis, Fibromyalgia and Irritable Bowel Syndromes Don L Goldenberg
8 [GO] 2024―Jan―11 A Population-Based Analysis of Rheumatology Care Patterns for Inflammatory Arthritis During COVID-19 in Alberta, Canada. Claire E.H. Barber, Brendan Cord Lethebe, Jessie Hart Szostakiwskyj, Cheryl Barnabe, Megan R.W. Barber, Steven Katz, et al. (+2)
9 [GO] 2023―Okt―29 Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study Emily N. Kowalski, Xiaosong Wang, Naomi J. Patel, Yumeko Kawano, Claire E. Cook, Kathleen M.M. Vanni, et al. (+6)
10 [GO] 2023―Okt―29 The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study Ezgi D. Batu, Fatma Gül Demirkan, Erdal Sag, Lovro Lamot, Ayodele Faleye, Edoardo Marrani, et al. (+5)
11 [GO] 2023―Mai―09 Correspondence on immune responses, rheumatoid arthritis and third dose of mRNA COVID-19 vaccine Amnuay Kleebayoon, Viroj Wiwanitkit
12 [GO] 2023―Feb―10 Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine Sara K. Tedeschi, Daniel H. Solomon, Yuezhou Chen, Jack Ellrodt, Mary Grace Whelan, Jacklyn Stratton, et al. (+9)
13 [GO] 2022―Dez―08 Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: a retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C) Namrata Singh, Vithal Madhira, Chen Hu, Amy L. Olex, Timothy Bergquist, Kathryn C. Fitzgerald, et al. (+3)
14 [GO] 2022―Nov―21 SARS-CoV-2 infection among patients with autoimmune rheumatic diseases; comparison between the Delta and Omicron waves in Israel Amir Bieber, Shay Brikman, Lena Novack, Snait Ayalon, Mahmoud Abu-Shakra, Lior Zeller, et al. (+2)
15 [GO] 2022―Okt―26 Factors Associated with COVID-19 Breakthrough Infection Among Vaccinated Patients with Rheumatic Diseases: A Cohort Study Naomi J. Patel, Xiaosong Wang, Xiaoqing Fu, Yumeko Kawano, Claire Cook, Kathleen M.M. Vanni, et al. (+6)
16 [GO] 2022―Sep―08 Reply on: COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis Ezgi Deniz Batu, Seher Sener, Seza Ozen
17 [GO] 2022―Jun―29 Risk of gout flares after COVID-19 vaccination: a case-crossover study Hui Li, Nicola Dalbeth, Zachary S Wallace, Jeffrey A Sparks, Xiaoxiao Li, Chao Zeng, et al. (+5)
18 [GO] 2022―Jun―10 COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis Ezgi Deniz Batu, Seher Sener, Seza Ozen
19 [GO] 2022―Mai―28 COVID-19 outcomes in patients with Dermatomyositis: a registry-based cohort analysis Haig Pakhchanian, Hiba Khan, Rahul Raiker, Sakir Ahmed, Chengappa Kavadichanda, Maryam Abbasi, et al. (+4)
20 [GO] 2022―Mai―19 DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study Michael Di Iorio, Claire E. Cook, Kathleen M.M. Vanni, Naomi J. Patel, Kristin M. D'Silva, Xiaoqing Fu, et al. (+9)
21 [GO] 2022―Feb―25 Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study Sandra Maximiano de Oliveira, Lucas Victória de Oliveira Martins, Ana Paula Lupino-Assad, Ana Cristina Medeiros-Ribeiro, Daniela Aparecida de Moraes, Ana Paula Toledo Del-Rio, et al. (+3)
22 [GO] 2021―Nov―07 SARS-CoV-2-Specific T-Cell Responses after COVID-19 Recovery in Patients with Rheumatic Diseases on Immunosuppressive Therapy Ana Lledó, Miriam Retuerto, Patricia Almendro-Vazquez, Mario Fernández-Ruiz, María Galindo, Rocío Laguna-Goya, et al. (+4)
23 [GO] 2021―Aug―20 Outcomes of COVID-19 in Patients with Rheumatoid Arthritis: A Multicenter Research Network Study in the United States Rahul Raiker, Charles DeYoung, Haig Pakhchanian, Sakir Ahmed, Chengappa Kavadichanda, Latika Gupta, Sinan Kardeş
24 [GO] 2021―Feb―10 Infection case of COVID-19 in patients with Rheumatic diseases receiving Biologic agents in Wuhan, China: a retrospective population-based analysis from a single center. You Song, Xiaojing Liu, Rong Du
25 [GO] 2020―Okt―02 Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members Achille Marino, Micol Romano, Maurizio Gattinara, Rolando Cimaz
26 [GO] 2020―Sep―29 How the COVID-19 pandemic has influenced pediatric rheumatology practice: results of a global, cross-sectional, online survey Ezgi Deniz Batu, Lovro Lamot, Erdal Sag, Seza Ozen, Yosef Uziel
27 [GO] 2020―Sep―22 Are glomerular patients treated with immunosupressed drugs more potected againts sever SARS-Covid -2?
28 [GO] 2020―Jul―24 Incidence and clinical course of COVID-19 in patients with rheumatologic diseases: a population-based study Ho SO, Joyce Wing-Yan MAK, Jacqueline SO, Grace LUI, Frankie LUN, Jolly LEE, et al. (+6)
29 [GO] 2020―Jul―06 Geographical variations in COVID-19 Perceptions and Patient Management: A National Survey of Rheumatologists Bella Mehta, Deanna Jannat-Khah, Carol A. Mancuso, Anne R. Bass, Carine J Moezinia, Allan Gibofsky, et al. (+2)
30 [GO] 2020―Jun―30 Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab Jan Leipe, Eva L Wilke, Matthias P Ebert, Andreas Teufel, Wolfgang Reindl
31 [GO] 2020―Jun―30 COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients Dr. Giuseppe A. Ramirez, Maria Gerosa, Lorenzo Beretta, Chiara Bellocchi, Lorenza M. Argolini, Luca Moroni, et al. (+6)
32 [GO] 2020―Mai―23 COVID-19 in Rheumatic Disease Patients on Immunosuppressive Agents Saika Sharmeen, Ahmed Elghawy, Fnu Zarlasht, Qing Ping Yao
33 [GO] 2020―Mai―16 Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs Xabier Michelena, Helena Borrell, Mireia López-Corbeto, María López-Lasanta, Estefanía Moreno, María Pascual-Pastor, et al. (+14)
34 [GO] 2020―Mai―16 Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei, China Yu Chen, Yuanji Dong, Shaozhe Cai, Cong Ye, Lingli Dong
 [1] 

34 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec